ProfileGDS4132 / 1566221_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 24% 25% 34% 30% 26% 21% 24% 27% 25% 33% 31% 25% 30% 27% 26% 27% 26% 33% 29% 34% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10155.638624
GSM201543Muscle PCOS pioglitazone 12150.479525
GSM201544Muscle PCOS pioglitazone 16186.405234
GSM201545Muscle PCOS pioglitazone 20181.931630
GSM201829Muscle PCOS pioglitazone 23166.750626
GSM201830Muscle PCOS pioglitazon 25148.57821
GSM201831Muscle PCOS pioglitazone 27152.51824
GSM201832Muscle PCOS pioglitazone 3167.021727
GSM201833Muscle PCOS pioglitazone 4155.5525
GSM201834Muscle PCOS pioglitazone 8179.339433
GSM201835Muscle PCOS after pioglitazone 10262.151131
GSM201836Muscle PCOS after pioglitazone 12249.324525
GSM201837Muscle PCOS after pioglitazone 16259.865330
GSM201838Muscle PCOS after pioglitazone 20256.50827
GSM201839Muscle PCOS after pioglitazone 23255.370826
GSM201840Muscle PCOS after pioglitazone 25262.93827
GSM201841Muscle PCOS after pioglitazone 27248.201126
GSM201842Muscle PCOS after pioglitazone 3267.089433
GSM201843Muscle PCOS after pioglitazone 4269.499629
GSM201844Muscle PCOS after pioglitazone 8279.921534